CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- 4 Exercise or conversion EVP, Technical Operations acquired 12,600 shares (option exercise)
- 4 Open-market sale Exec. Vice Pres. HR sold 2,826 shares at $6.12 ($17,295)
- 4 Open-market sale EVP, R&D, Chief Scientific Off sold 7,035 shares at $6.12 ($43,054)
- 4 Shares withheld for taxes Chairman of the Board & CEO gave up 27,011 shares (to pay taxes)
- 4 Open-market sale Exec VP Finance, CFO sold 10,306 shares at $6.33 ($65,237)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chairman, CEO & President acquired 36,000 shares (option exercise)
- 4 Exercise or conversion EVP, R&D, Chief Scientific Off acquired 2,250 shares (option exercise)
- 4 Exercise or conversion Exec. Vice Pres. HR acquired 3,000 shares (option exercise)
- 4 Exercise or conversion Exec VP Finance, CFO acquired 3,000 shares (option exercise)
- 4 Exercise or conversion EVP - Technical Operations acquired 3,000 shares (option exercise)
- 4 Open-market buy Director bought 10,000 shares at an average $4.06 ($40,552)
- 4 Open-market buy Director bought 15,000 shares at $3.77 ($56,514)
- 4 Open-market buy Director bought 10,000 shares at an average $3.64 ($36,429)
Page 11 of 28 · 560 filings